Testogel is a widely prescribed testosterone replacement therapy (TRT) in the UK, used to treat male hypogonadism—a condition where the body produces insufficient testosterone. Many men considering or starting treatment ask: does Testogel work? Clinical evidence confirms that Testogel effectively raises serum testosterone levels in men with confirmed hypogonadism, leading to improvements in libido, energy, mood, and muscle mass. However, individual response varies, and success depends on accurate diagnosis, correct application technique, regular monitoring, and realistic expectations. This article examines the clinical evidence, timeframes for symptom improvement, and factors that influence Testogel's effectiveness, providing a comprehensive guide for patients and healthcare professionals.

What Is Testogel and How Does It Work?

Testogel is a transdermal testosterone replacement therapy (TRT) licensed in the UK for treating male hypogonadism—a condition characterised by abnormally low testosterone levels. In the UK, Testogel is available as a gel containing testosterone at a concentration of 16.2 mg per gram (1.62%), applied once daily to clean, dry, intact skin on the shoulders and upper arms.

The active ingredient, testosterone, is absorbed through the skin into the bloodstream, where it exerts its physiological effects. Once absorbed, testosterone binds to androgen receptors in various tissues, influencing muscle mass, bone density, libido, mood, and energy levels. The transdermal route provides relatively stable serum testosterone levels throughout the day, avoiding the pronounced peaks and troughs associated with some intramuscular injection regimens.

Mechanism of action: After application, testosterone penetrates the stratum corneum and enters systemic circulation. Peak serum concentrations are typically reached within a few hours, and steady-state levels are generally achieved after several days of consistent use. The gel formulation allows for dose adjustments based on individual response and blood test results, providing flexibility in management.

Testogel is prescribed when blood tests confirm low testosterone levels (measured on at least two early-morning samples) accompanied by symptoms such as reduced libido, fatigue, erectile dysfunction, or loss of muscle mass. It is contraindicated in men with known or suspected prostate or breast cancer, and should be used with caution in those with severe cardiac, hepatic, or renal impairment. It is not suitable for women or children, and should only be used under medical supervision following a confirmed diagnosis of hypogonadism.

Important safety advice: Testosterone replacement therapy suppresses spermatogenesis and can impair fertility. Men seeking to father children should not start TRT and should be referred to a specialist for alternative management. Proper application technique is essential: apply the gel to the shoulders and upper arms only (not to the genitals, abdomen, or broken or irritated skin), allow it to dry fully, wash your hands thoroughly with soap and water after application, and cover the application site with clothing once dry. Avoid skin-to-skin contact with others—particularly women (especially those who are pregnant) and children—until the gel has dried and the area is covered, to prevent inadvertent transfer that could cause virilisation or precocious puberty.

Clinical Evidence: Does Testogel Effectively Raise Testosterone?

Clinical trials and real-world evidence demonstrate that Testogel effectively raises serum testosterone levels in men with confirmed hypogonadism. Pivotal studies submitted to the MHRA and EMA have shown that daily application of Testogel restores testosterone concentrations to within the laboratory-specific adult male reference range in the majority of patients. These studies also documented improvements in hypogonadal symptoms, including increased libido, enhanced mood, improved energy levels, and gains in lean body mass. The transdermal delivery system provides more stable hormone levels compared to depot injections, reducing the fluctuations that can affect symptom control and tolerability.

UK guidance from NICE Clinical Knowledge Summaries, the Society for Endocrinology, and the British Society for Sexual Medicine acknowledges testosterone replacement therapy as an appropriate treatment for men with symptomatic hypogonadism confirmed by at least two early-morning serum testosterone measurements. Transdermal gels such as Testogel are recognised as one option alongside other formulations (e.g., intramuscular injections and alternative gels), with choice guided by patient preference, tolerability, and clinical circumstances.

However, individual response varies. The usual starting dose of Testogel 16.2 mg/g is 40.5 mg of testosterone once daily, with typical maintenance doses ranging from 20.25 mg to 81 mg daily, adjusted according to serum testosterone levels and clinical response. Some men may require dose titration upwards or downwards if levels remain outside the reference range or if symptoms persist. Factors such as skin absorption variability, application technique, and concurrent medical conditions can influence outcomes.

Regular monitoring is essential to ensure therapeutic efficacy and safety. Blood tests (serum testosterone, ideally taken in the morning at a consistent time relative to gel application) should be performed at baseline, after approximately 3 months, at 6 and 12 months, and then annually. In addition, haematocrit should be checked at baseline, at 3–6 months, and annually thereafter; if haematocrit exceeds 54%, the dose should be reduced or treatment stopped. Prostate-specific antigen (PSA) and digital rectal examination (DRE) should be performed at baseline and during follow-up according to individual risk; any abnormal DRE findings or unexpected rise in PSA warrants prompt urology referral. Liver function tests and lipid profiles may also be monitored as clinically indicated.

While Testogel is clinically effective for raising testosterone, it is not a panacea. Symptom improvement depends on accurate diagnosis, appropriate patient selection, adherence to treatment protocols, and management of comorbidities. If there is no symptomatic improvement after approximately 6 months despite testosterone levels within the reference range, the diagnosis should be reconsidered and alternative causes of symptoms explored.

How Long Does Testogel Take to Work?

The timeframe for Testogel to produce noticeable effects varies depending on the symptom being addressed and individual patient factors. Serum testosterone levels typically begin to rise within hours of the first application, with steady-state concentrations usually achieved after 3–7 days of consistent daily use. However, biochemical changes do not always correlate immediately with symptomatic improvement.

Libido and sexual function may begin to improve within 2–4 weeks, though some men report changes as early as one week. Erectile function and overall sexual satisfaction often show more gradual improvement over 3–6 months. Mood and energy levels can start to lift within the first month, but optimal benefits are generally observed after 6–12 weeks of treatment.

Physical changes such as increased muscle mass and strength, reduced fat mass, and improved bone density develop more slowly. Muscle-related improvements may become apparent after 3–6 months, while changes in bone mineral density require at least 12 months of sustained therapy to be clinically significant.

It is important to set realistic expectations. Some symptoms, particularly those related to mood or cognitive function, may have multifactorial causes, and testosterone replacement alone may not fully resolve them. Adherence is critical—missing doses or inconsistent application can delay or diminish therapeutic effects.

Patients should be reviewed after 3 months of treatment with repeat testosterone blood tests (taken in the morning at a consistent time relative to gel application, as specified in the product information) to assess biochemical response. At this and subsequent reviews, safety monitoring should include haematocrit and, where appropriate, PSA and DRE. If testosterone levels remain outside the reference range or symptoms persist despite adequate testosterone concentrations, dose adjustment or further investigation may be warranted. If there is no symptomatic benefit after approximately 6 months despite normalised testosterone, the diagnosis should be reconsidered and treatment may need to be stopped. Patience and ongoing communication with your GP or endocrinologist are key to achieving the best outcomes.

Factors That Affect Testogel Effectiveness

Several factors can influence how well Testogel works, and understanding these can help optimise treatment outcomes.

Application technique is paramount. The gel must be applied to clean, dry, intact skin on the shoulders and upper arms only. Do not apply to the genitals, abdomen, or to broken or irritated skin. After application, allow the gel to dry for 3–5 minutes before dressing. Wash your hands thoroughly with soap and water immediately after application. Avoid washing or showering the application site for at least 2 hours after applying the gel, as this can reduce absorption. Cover the application site with clothing once the gel has dried.

Skin-to-skin contact with others—particularly women (especially those who are pregnant) and children—must be avoided until the gel has dried and the area is covered with clothing. Inadvertent transfer can cause virilisation in women or precocious puberty in children, so careful hygiene and awareness are essential. If contact does occur, the affected person should wash the area with soap and water as soon as possible.

Individual variability in skin absorption plays a significant role. Some men absorb testosterone more efficiently than others due to differences in skin thickness, blood flow, or dermal permeability. This is why dose titration based on blood test results is necessary.

Concurrent medications can affect testosterone therapy. According to the UK Summary of Product Characteristics (SmPC), Testogel may interact with:

• Coumarin anticoagulants (e.g., warfarin): testosterone may enhance their effect, so INR should be monitored closely, especially when starting or stopping TRT.

• Antidiabetic medicines: testosterone may improve insulin sensitivity and lower blood glucose, increasing the risk of hypoglycaemia; blood glucose should be monitored and antidiabetic doses adjusted as needed.

• ACTH and corticosteroids: concurrent use may increase the risk of fluid retention and oedema, particularly in patients with cardiac, renal, or hepatic disease.

• Ciclosporin: testosterone may increase ciclosporin levels, requiring monitoring.

Always inform your doctor or pharmacist of all medicines you are taking, including over-the-counter and herbal products.

Lifestyle factors also matter. Obesity, excessive alcohol consumption, poor sleep, and chronic stress can all negatively impact testosterone levels and treatment response. Addressing these through weight management, improved sleep hygiene, and stress reduction can enhance Testogel's effectiveness.

Underlying health conditions such as uncontrolled diabetes, thyroid disorders, or pituitary disease may blunt the response to TRT. Comprehensive evaluation and management of comorbidities are essential.

Finally, adherence is critical. Missing doses or inconsistent application undermines treatment efficacy. Patients should be counselled on the importance of daily use and encouraged to integrate application into their morning routine. If side effects or practical difficulties arise, these should be discussed with a GP or endocrinologist rather than discontinuing treatment independently.

Reporting side effects: If you experience any side effects, talk to your doctor or pharmacist. You can also report suspected side effects directly via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or by downloading the Yellow Card app. Reporting helps provide more information on the safety of medicines.

Frequently Asked Questions